Topic: chief medical officer
Sarepta brought on Biogen’s VP of late-stage programs, Gilmore O’Neill, as chief medical officer, after their previous hire left after 8 months.
James Pennington joined AzurRx BioPharma as CMO as the company aims to launch a phase 2 trial of its lead candidate in cystic fibrosis this year.
Galecto Biotech hired Richard Marshall, head of fibrosis discovery at GlaxoSmithKline, to be CMO as it moves into late-phase trials of its IPF drug.
Urovant brought on Allergan’s Cornelia Haag-Molkenteller as chief medical officer shortly after launching a phase 3 trial of its sole drug candidate.
Parisian gene therapy biotech GenSight says its chief medical officer, Mohamed Genead, M.D., has stepped down for “personal reasons.”
Sorrento has brought on a former Celgene Chief Medical Officer Dr. Jerome Zeldis as CMO and President of Clinical Development.